CME Group's EPS (Basic) for the
three
months ended in Dec. 2023 was $2.24.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $8.87.
CME Group's EPS without NRI for the
three
months ended in Dec. 2023 was $2.37.
Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $6.46.
During the past 12 months, CME Group's average EPS without NRIGrowth Rate was 248.40% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 19.50% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 7.90% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 6.10% per year.
During the past 13 years, CME Group's highest 3-Year average EPS without NRI Growth Rate was 49.70% per year. The lowest was -20.80% per year. And the median was 12.95% per year.
CME Group Earnings per Share (Diluted) Historical Data
The historical data trend for CME Group's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of CME Group's Earnings per Share (Diluted)
For the Financial Data & Stock Exchanges subindustry, CME Group's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CME Group's PE Ratio Distribution in the Capital Markets Industry
For the Capital Markets industry and Financial Services sector, CME Group's PE Ratio distribution charts can be found below:
* The bar in red indicates where CME Group's PE Ratio falls into.
CME Group Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
CME Group's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $8.87
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
CME Group (NAS:CME) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
CME Group Earnings per Share (Diluted) Related Terms
Thank you for viewing the detailed overview of CME Group's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The CME was founded in 1898 and in 2002 completed its initial public offering. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival, CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX in 2018 it has also expanded into cash foreign exchange, fixed income trading, and collateral optimization.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CME has been successfully added to your 